Bridges J, Oram D
Princess Anne Hospital, Southampton.
Br J Hosp Med. 1993;49(3):191-9.
The management of patients with advanced gynaecological malignancies remains a therapeutic challenge and relies on careful staging of the disease and individualization of treatment regimes. This article explores the historical and current therapeutic options available for women with disease originating from the vulva, cervix, endometrium and ovary.
晚期妇科恶性肿瘤患者的管理仍然是一项治疗挑战，并且依赖于疾病的仔细分期和治疗方案的个体化。本文探讨了针对源自外阴、宫颈、子宫内膜和卵巢疾病的女性患者，过去和当前可用的治疗选择。
